The objective of this paper is to share our experience in creating multivariate predictive models (PLS) for definitive and intermediate treatment outcomes in DKA patients. The research design involved a retrospective cohort of 16 DKA patients who were admitted during a period of 11 months. The clinical dataset was categorized into admission (disturbance variables that cannot be altered), treatment (manipulated variables that can be altered) and treatment outcome variables. PLS models with manipulated variables was found to be clinically preferable than the model with both manipulated and disturbance variables. 10 predictor variables were found to be important in PLS model with manipulated variables, out of which total intravenous insulin before conversion to subcutaneous insulin was found to be the most important predictor.
INTRODUCTION
Application of modeling has benefits not only in chemical systems but also in various new challenging domains. Biomedical systems area is one such domain which has immense potential for application of these techniques. Model based control of blood glucose (BG) in diabetic patients is one biomedical problem where modeling and model-based treatment strategies have been applied. Uncontrolled BG levels lead to various short and long term diabetic complications like diabetes ketoacidosis (DKA), neuropathy, nephropathy, retinopathy and increased cardiovascular risk and mortality. This paper focuses on identification of multivariate models and its use in the treatment of a shortterm complication in diabetes: DKA.
Motivation and Background
DKA has been found to be responsible for 500,000 hospital days in USA, and may occur in both type 1 and type 2 diabetes (T1DM and T2DM) patients (Kitabchi et al. 2009 ). It is a serious medical emergency and is the most common cause of death in children and adolescents with T1DM. DKA is characterized by uncontrolled hyperglycaemia, metabolic acidosis and the presence of ketone bodies in blood and urine Nyenwe 2006, Kitabchi et al. 2009 ). The biochemical criteria for diagnosis of DKA are: (i) blood glucose levels > 14 mmol/l (> 250 mg/dl), (ii) pH < 7.3, (iii) presence of ketones in serum and/or urine, and serum bicarbonate level < 18 mmol/l. Management often takes place in the intensive care unit (ICU) setting with insulin and fluid/ electrolyte replacement therapies and continuous monitoring of clinical parameters like heart rate, urine output and blood pressure and biochemical parameters like serum glucose, electrolytes, ketone levels and anion gap. These continue until resolution of DKA which occurs when: blood glucose < 11.1 mmol/l (< 200 mg/dl), pH > 7.3, and serum bicarbonate > 15 mEq/l with resolution of ketonemia. Subsequently, intravenous insulin is converted to subcutaneous insulin and intravenous fluid therapy is reduced or stopped. Patients are often discharged only a few days later as they require further stabilisation, education to prevent a further episode, titration of subcutaneous insulin and treatment of the underlying precipitants of DKA.
Optimal management of DKA can minimize the time to resolution, length of the hospital stay (total number of days spent by the patient in hospital) and medical expenses. A reliable model which involves the important predictor variables that can affect the treatment outcomes would be very useful for devising optimal DKA treatment strategies. Most of the available literature on DKA use univariate models to identify the important predictors for glycaemic control in DKA patients , Maldonado et al. 2003 , length of hospital and ICU stays (Freire et al. 2002) . Some of the important predictors identified in these studies were: ethnicity, type of diabetes, precipitating cause (Freire et al. 2002) , preserved beta cell mass , Maldonado et al. 2003 . Some studies have discussed the application of multiple linear regression models (MLR) to predict the resolution time, length of hospital stay and various other intermediate treatment outcomes (Marill 2004) . However, these studies did not consider the correlations that exist between the response variables. Multivariate modeling tools like partial least squares (PLS) are able to handle correlated input and output variables.
The main objective of this paper is to develop predictive multivariate PLS model for definitive and intermediate treatment outcomes of DKA patients, and also to identify the important predictors that influence the definitive treatment outcomes (resolution time and length of hospital stay) and intermediate outcomes like hypoglycaemia (occurrence and frequency), hypokalemia (occurrence) and glucose/ bicarbonate/anion gap times to achieve normalization, hours till conversion, hours till HC < 14. PLS models with the important predictors can be useful to devise treatment protocols for optimal infusion of insulin, fluid and electrolytes (per hour or over a period of 24-48 hours)
RESEARCH DESIGN AND METHODS
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Retrospective Data
We conducted a retrospective analysis on 16 DKA patients admitted to SGH between January 2009 and November 2009. The clinical data was retrieved from the medical notes, clinical charts and computer records. The patient cohort comprised of three ethnic origins: Chinese, Malay and Indian. The duration of diabetes in this cohort varied between 2 years and 25 years. Most of the patients had pre-existing type 2 diabetes. The retrieved clinical data was categorized into three different data blocks based on the time at which the variables were recorded/measured as: admission variables, treatment variables and treatment outcome variables.
[A]. Admission variables: This block comprises of variables that were obtained directly from patients or from the patient history (like age, gender, ethnicity, type of DM, Previous DKA, etc.) and variables that were measured at the time of admission (like admission systolic/diastolic BP, pulse rate, potassium (K), Na, pH, serum/urine ketones, etc). A statistical summary of these variables is provided in Table 1 . In this cohort, the mean values of admission variables like glucose, pH, bicarbonate and serum/urine ketone levels in Table 1 comply with the diagnostic criteria for occurrence of DKA.
[B]. Treatment variables: Treatment was initiated in ICU with insulin and fluid replacement therapies. Hence, this block comprises of variables (shown in Table 2 ) which were related to both these therapies. Insulin therapy was accomplished with initial bolus insulin dose, continuous intravenous insulin infusion and subcutaneous insulin infusion. 14 out of 16 patients were given an initial bolus dose. The variables like amount of insulin bolus, and time at which the bolus insulin was initiated were related to initial bolus dose. Following the initial dose, all the patients were treated with i.v. insulin until the crisis was resolved. Insulin infusion rate and total i.v insulin dose were the two variables related to insulin infusion. Upon DKA resolution, subcutaneous insulin therapy was initiated. Fluid replacement therapy was accomplished with infusion of saline, and electrolyte replacement was accomplished with fluids like K, bicarbonate, and phosphate.. In addition to insulin and fluid therapy, antibiotics were also given to patients during the treatment. 
Data Pre-Treatment
[A]. Definition of input (X) and output (Y) blocks: In Subsection 2.3, the variables were categorized based on the clinical scenario. From systems engineering point of view, for purposes of modeling, all the variables should be categorized into input and output blocks. Generally, an input block comprises of manipulated variables (variables which can be altered) and the disturbance variables (variables which cannot be altered). In this analysis, the treatment variables in Table 2 were defined as manipulated variables and the 8th IFAC Symposium on Advanced Control of Chemical Processes Furama Riverfront, Singapore, July 10-13, 2012
admission variables in Table 1 were defined as disturbance variables. On the other hand, output block was defined as a combination of both intermediate and definitive treatment outcome variables (Table 2) .
[B]. Dummy coding of categorical variables: Categorical variables cannot be directly included into a regression model as it will not result in meaningful interpretation. Dummy coding enables one way of employing the categorical variables into various regression models. In general, a categorical variable with k levels will be transformed into k-1 new variables (Stockburger 1997 Tables 1 and 2 were dummy coded (Data not shown).
[C]. Training and test data sets: The original dataset was split into training and test datasets. The split was performed in an organised way such that there were 14 and 2 samples in the training and test datasets, respectively. Hence, the maximum possible training + test sample combinations would be 16 C 2 = 120. However, one or two combinations in the training dataset contained some variables (like i.v. bicarbonate, previous DKA) with zero standard deviation. Such combinations were not considered in model development process. In such cases, handling the raw data as such will bias the model towards the variables with higher variances (although those variables may not play an important role in prediction). In our retrospective cohort, variables of different magnitudes exist (in the order of 10, 10 2 and 10 3 ). Hence, the variables in both the X and Y blocks were autoscaled (as Xs and Ys) i.e. each column was mean centered and scaled to unit variance. Fig. 1 . The mathematical representation of PLS models is well established and can be found in the literature (Geladi and Kowalski 1986 , Lakshminarayanan et al. 1997 , Wold et al. 2001 ).
PLS Regression Modeling Technique
Fig. 1 General structure of PLS outer and inner models
[A]. Cross validation: Generally, the optimal number of PLS dimensions (np) can be decided based on cross validation using the training dataset or based on the percentage of variance (information) captured by the components. In this analysis, optimal np was selected based on cross validation, as per the following procedure: (i) The training dataset (with 14 samples) was split randomly into 2 parts (say A and B); (ii) PLS models were developed for different dimensions using A; (iii) Predictive ability was tested using B (squared prediction error (SPE) was calculated); (iv) Steps (i) to (iii) were repeated for 20 times; (v) Cumulative SPE was calculated and plotted against number of PLS dimension. This plot is referred to as PRESS (predictive residual sum of squares) plot. The number of PLS dimensions with the lowest PRESS was selected as the optimal np.
[B]. PLS model with optimal np: Following this, PLS model was developed using the optimal np with the full training dataset (14 samples). This model was validated with the test dataset (2 samples). All the above explained cross validation steps followed by the PLS model development and validation steps were repeated for all the possible combinations of training and test datasets (i.e. about 120 combinations). Sum of the squared error (SSE) and percentage of variance (information) captured from the X and Y blocks were calculated for each combination of training and test dataset.
[C]. Selection of important predictor variables: Important predictors were selected based on a statistic called variable influence on projection (VIP). VIP value of i th X s block variable with optimal np can be computed as: 
RESULTS AND DISCUSSION
PLS models were developed and validated for two different cases, which were defined based on the nature of input blocks. The output blocks were same for both the cases, which contained 8 intermediate responses and 2 definitive responses.
Case 1: PLS model with Manipulated Variables
There were 15 manipulated variables in the retrospective dataset (including 3 new dummy coded variables for antibiotic usage) and 14 samples in the training data. The optimal np for different combinations of training and test datasets was determined by cross validation. The optimal np varied between 2 and 15 for different combinations. Fig. 2 shows the SSE ranges obtained for different combinations of training and test datasets (in the prediction of both the definitive variables). Validation of testing dataset resulted in low SSE ranges for majority of combinations. In case of prediction of resolution time, SSE was < 250 (hours) 2 in 112 combinations (Fig. 2[A] ) whereas, in the case of length of hospital days, SSE was < 250 (days) 2 in 99 combinations (Fig. 2[B] ). From this, it can be inferred that the prediction of time taken to resolution time was better than the prediction of length of hospital stay. Percentage of variance captured from the X-and Y-blocks, represent the percentage of information captured from the original dataset. In this case, 80 combinations of training and test datasets captured 50-100% of variance from the X-and Y-blocks. 51 out of 80 combinations captured 50-60% of variance from the original blocks (Fig 3) . Although this percentage may be considered as low it is sufficiently robust for biological datasets like DKA, as biological datasets are noisier. 10 out of 15 manipulated variables were found to be important (since their VIP values were found to be ≥ 0.8). All the four insulin therapy variables were found to be important predictors of the two definitive variables. Total i.v. insulin given till conversion to s.c. insulin was found to be the most important predictor variable, which was followed by the amount of bolus insulin. Also, 5 out of 8 fluid therapy variables were found to be important. The important predictor variables in decreasing order of importance (i.e. starting from the variable with highest VIP to the variable with VIP = 0.8) are listed in Table 3. PLS models with important predictor variables were developed for different combinations of training and test datasets. The SSE range plots and percentage variance plots for the PLS models with important predictor variables are shown in Figs. 4 and 5. From Fig. 4 , it can be inferred that most of the combinations predicted the two definitive 8th IFAC Symposium on Advanced Control of Chemical Processes Furama Riverfront, Singapore, July 10-13, 2012 variables with low SSE ranges. Hence, PLS model with important predictors did not increase the SSE ranges. On the other hand, comparing Fig. 3[B] with Fig 5[B] , it can be inferred that in some combinations there was a slight decrease in percentage of information (from 50% to 45%) captured from the Y-block. Hence, further reduction of important predictor variables would decrease the percentage of information captured in Y-block. The reasons for poor prediction of definitive response variables in 50% of patients could be due to poor prediction of one or more intermediate responses. The SSE prediction ranges for 8 intermediate responses can be seen in Fig. 7 . In case of intermediate treatment outcome variables, it can be inferred that frequencies of low SSE ranges were occurring in most of the combinations of training and test datasets. However, in case of predicting the bicarbonate time to achieve normalization (Fig 7[C] ), SSE ranges for some combinations were >1000 (hours) 2 . Also, in the case of occurrence of hypokalemia predictions (Fig. 7[F] ), SSE ranges were larger and unrealistic. In the predictions of hypoglycaemic occurrence (Fig. 7[D] ), although SSE ranges were smaller, the predictions were almost realistic in about 48 combinations only. Hypoglycaemia/hypokalemia occurrences are categorical variables with 2 levels, Yes/No. Hence, predictions of these two categorical variables could be realistic if the SSE ranges are either 0 (for correct prediction) or 4 (for wrong prediction). Such realistic values could be observed in the predictions of hypoglycaemia (at least for some combinations) but not in hypokalemia occurrences. The larger differences in SSE ranges of these two categorical intermediate response variables could be the reason for poor prediction of definitive responses in some patients (as shown in parity plots of Fig. 6 ). This could be due to lesser number 8th IFAC Symposium on Advanced Control of Chemical Processes Furama Riverfront, Singapore, July 10-13, 2012 of samples than the variables. Hence, in order to get a reliable model more number of samples should be collected. PLS predictions can very likely be improved with availability of more data samples. 
Case 2: PLS model with Manipulated and Disturbance Variables
There were 59 predictor variables in this case (15 manipulated and 44 disturbance variables). In majority of the combinations for training and test datasets, PLS model captured 90-100% of variance from the original X and Y blocks. This was significantly higher when compared to PLS model with manipulated variables only. Also, SSE ranges in majority of combinations were low. However, validation results showed that predictions were not improved when compared to Case 1. This may be due to the problem of larger number of variables compared to the number of samples. Another interesting observation was the identification of important predictor variables. Disturbance variables like precipitating cause, type of diabetes, and age dominated the manipulated variables. Although this model could be of some use in prediction alone, it does not help determine the optimal doses of therapy variables. Instead it would seem that the manipulated variables alone helped in determining the two definitive responses in 50% of the patient population. In this context, clinicians would prefer Case 1 model that contained manipulated variables in the X-block.
4. CONCLUSIONS Greater number of variables compared to samples is one of the practical challenges in modeling. The current dataset is a good example of this. The PLS model with manipulated variables showed a reasonable prediction in about 50% of the patients. Further improvement in the model could be possible with a larger sample size which will be addressed in our future works.
